Wanders R J, Kos M, Roest B, Meijer A J, Schrakamp G, Heymans H S, Tegelaers W H, van den Bosch H, Schutgens R B, Tager J M
Biochem Biophys Res Commun. 1984 Sep 28;123(3):1054-61. doi: 10.1016/s0006-291x(84)80240-5.
The activity of peroxisomal enzymes was studied in human liver and cultured human skin fibroblasts in relation to the finding (Goldfischer, S. et al. (1973) Science 182, 62-64) that morphologically distinct peroxisomes are not detectable in patients with the cerebro-hepato-renal (Zellweger) syndrome. In homogenates of liver from the patients, dihydroxyacetone phosphate acyltransferase, a membrane-bound peroxisomal enzyme, is deficient (Schutgens, R.B.H., et al. (1984) Biochem. Biophys. Res. Commun. 120, 179-184). In contrast, there is no deficiency of the soluble peroxisomal matrix enzymes catalase, L-alpha-hydroxyacid oxidase and E-aminoacid oxidase. Catalase is also not deficient in homogenates of cultured skin fibroblasts from the patients. The results of digitonin titration experiments showed that in control fibroblasts at least 70% of the catalase activity is present in subcellular particles distinct from mitochondria or lysosomes. In contrast, all of the catalase activity in fibroblasts from Zellweger patients is found in the same compartment as the cytosolic marker enzyme lactate dehydrogenase.
针对脑肝肾(泽尔韦格)综合征患者无法检测到形态上不同的过氧化物酶体这一发现(戈德菲舍尔,S.等人(1973年)《科学》182卷,62 - 64页),研究了人肝脏和培养的人皮肤成纤维细胞中的过氧化物酶体酶活性。在患者肝脏匀浆中,膜结合的过氧化物酶体酶磷酸二羟丙酮酰基转移酶缺乏(舒特根斯,R.B.H.等人(1984年)《生物化学与生物物理研究通讯》120卷,179 - 184页)。相比之下,可溶性过氧化物酶体基质酶过氧化氢酶、L-α-羟酸氧化酶和E-氨基酸氧化酶并不缺乏。患者培养的皮肤成纤维细胞匀浆中的过氧化氢酶也不缺乏。洋地黄皂苷滴定实验结果表明,在对照成纤维细胞中,至少70%的过氧化氢酶活性存在于与线粒体或溶酶体不同的亚细胞颗粒中。相比之下,泽尔韦格综合征患者成纤维细胞中的所有过氧化氢酶活性都与胞质标记酶乳酸脱氢酶存在于同一区室中。